Tehran University of Medical Sciences

Science Communicator Platform

Share By
Impact of Various Culture Conditions on Ex Vivo Expansion of Polyclonal T Cells for Adoptive Immunotherapy Publisher Pubmed



Ghaffari S1, 2 ; Torabirahvar M1, 3 ; Omidkhoda A4 ; Ahmadbeigi N1
Authors

Source: APMIS Published:2019


Abstract

Currently, adoptive immunotherapy is considered as one of the leading treatments in cancer. Successful adoptive immunotherapy depends on producing large numbers of desired T cells ex vivo for infusion. This requires an effective protocol for maximum functional T-cell expansion while keeping the time and costs to a minimum. Current T-cell expansion protocols are diverse in their methodology, and a universal protocol of expansion is wanting. Also, new findings regarding T-cell biology, signaling, and activation have reshaped the strategies of T-cell propagation over the years, introducing new ways to expand T cells. Here, we reviewed different conditions for blood-derived polyclonal T-cell expansion so as to elucidate the influential factors of T-cell expansion and their efficacy. © 2019 APMIS. Published by John Wiley & Sons Ltd
Other Related Docs
5. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
8. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
12. Multiple Myeloma, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
17. Generation of Cd19-Targeted Chimeric Antigen Receptor T Cells, Archives of Iranian Medicine (2019)
20. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers (2015)